SG/CALL/STRYKER CORP./200/0.1/21.06.24 Stock

Warrant

DE000SQ4HB82

Market Closed - Deutsche Boerse AG 15:35:56 2024-05-31 EDT
12.74 EUR -1.85% Intraday chart for SG/CALL/STRYKER CORP./200/0.1/21.06.24
1 month-1.32%
3 months-9.00%
Date Price Change
24-05-31 12.74 -1.85%
24-05-30 12.98 -0.46%
24-05-29 13.04 +2.60%
24-05-28 12.71 +5.56%
24-05-27 12.04 -3.99%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 03:35 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SQ4HB8
ISINDE000SQ4HB82
Date issued 2022-11-16
Strike 200 $
Maturity 2024-06-21 (19 Days)
Parity 10 : 1
Emission price 5.11
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 14.83
Lowest since issue 4.94
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 1.703
Difference Strike -140.6 $
Difference Strike %-70.29%
Intrinsic value 12.96

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.1 USD
Average target price
373.1 USD
Spread / Average Target
+9.38%
Consensus